- Fund Type: Open-End Fund
- Objective: Sector Fund-Health & Biotech
- Asset Class: Equity
- Geographic Focus: Global
BlackRock Health Sciences Opportunities Portfolio
+ Add to WatchlistSHSSX:US
39.94 USD 0.03 0.08%As of 09:29:30 ET on 05/24/2013.
Snapshot for BlackRock Health Sciences Opportunities Portfolio (SHSSX)
| Year To Date: | +23.50% | 3-Month: | +13.18% | 3-Year: | +19.94% | 52-Week Range: | 28.40 - 40.35 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +2.62% | 1-Year: | +37.33% | 5-Year: | +13.70% | Beta vs SPX: | 0.85 |
Fund Profile & Information for SHSSX
BlackRock Health Sciences Opportunities Portfolio is an open-end fund incorporated in the USA. The Fund's objective is long-term growth of capital. The Fund normally invests at least 80% of total assets in securities of companies in health sciences and related industries.
| Inception Date: | 10-16-2000 | Telephone: | 1-800-441-7762 |
|---|---|---|---|
| Managers: | THOMAS P CALLAN / H ERIN XIE | ||
| Web Site: | www.blackrock.com | ||
Fundamentals for SHSSX
| NAV | (on 2013-05-24) 39.94 |
|---|---|
| Assets (M) | (on 2013-05-24) 2,663.63 |
| Fund Leveraged | N |
| Minimum Investment | 2,000,000.00 |
| Minimum Subsequent Investment | 0.00 |
Dividends for SHSSX
| Dividend Type | Income |
|---|---|
| Dividend Frequency | Annual |
| Last Dividend Net | (on 2012-12-12) 0.18 |
| Dividend Yield (ttm) | 6.02 |
Fees & Expenses for SHSSX
| Front Load | 0.00 |
|---|---|
| Back Load | 0.00 |
| Current Mgmt Fee | 0.73 |
| Redemption Fee | 0.00 |
| 12b1 Fee | 0.00 |
| Expense Ratio | 0.98 |
Top Fund Holdings for SHSSX
Filing Date: 12/31/2012| Name | Position | Value | % of Total |
|---|---|---|---|
| Pfizer Inc | 4,340,140 | 108,850,711 | 5.513% |
| Eli Lilly & Co | 1,603,600 | 79,089,552 | 4.005% |
| Johnson & Johnson | 1,043,900 | 73,177,390 | 3.706% |
| Roche Holding AG | 353,600 | 71,491,268 | 3.621% |
| Sanofi | 735,200 | 69,719,311 | 3.531% |
| Celgene Corp | 748,152 | 58,894,525 | 2.983% |
| Novartis AG | 833,900 | 52,680,203 | 2.668% |
| Express Scripts Holding Co | 920,447 | 49,704,138 | 2.517% |
| Alexion Pharmaceuticals Inc | 495,101 | 46,445,425 | 2.352% |
| Biogen Idec Inc | 309,400 | 45,379,698 | 2.298% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page